Ricardo Celestino

2.6k citations
27 papers · 838 indexed · h-index 17

Ricardo Celestino

27 papers receiving 824 citations

Peers

Ricardo Celestino
Comparison fields: 5 of 71
  • Endocrinology, Diabetes and Metabolism 364
  • Cell Biology 209
  • Aging 12
  • Pathology and Forensic Medicine 119
  • Oncology 163
Replace Tina Di Palma with:
Tina Di Palma Italy
Lee B. Jacoby United States
Anant Mamidi Italy
Aparna Gupta United States
Shirley M. Myers Canada
Idriss M. Bennani-Baı̈ti Austria
Matthew D. Schroeder United States
Sheng‐Ben Liang Japan
Jan Osinga Netherlands
David Van Mater United States
Ricardo Celestino relative to Tina Di Palma Italy Tina Di Palma's profile →
Citations per field
00.5×
Tina Di Palma · 1×
Citations per year

Countries citing papers authored by Ricardo Celestino

Since Specialization
Citations

This map shows the geographic impact of Ricardo Celestino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ricardo Celestino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ricardo Celestino more than expected).

Fields of papers citing papers by Ricardo Celestino

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ricardo Celestino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ricardo Celestino. The network helps show where Ricardo Celestino may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ricardo Celestino, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ricardo Celestino Line = papers co-authored together Ricardo Celestino links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 202230
3 201934
4 201831
5 201850
6 20159
7 201418
8 201491
9 201424
10 201432
11 201440
12 20137
13 201215
14 201237
15 201214
16 201168
17 201115
18 201115
19 201015
20 200810

About Ricardo Celestino

Ricardo Celestino is a scholar working on Endocrinology, Diabetes and Metabolism, Gastroenterology and Cell Biology, having authored 27 papers that have together received 838 indexed citations. Recurring topics across this work include Thyroid Cancer Diagnosis and Treatment (14 papers), Genetic factors in colorectal cancer (6 papers), Microtubule and mitosis dynamics (6 papers), Cellular transport and secretion (3 papers), Photosynthetic Processes and Mechanisms (3 papers), Gastrointestinal Tumor Research and Treatment (3 papers), Cancer-related Molecular Pathways (3 papers) and Genomics and Chromatin Dynamics (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (364 citations), Cell Biology (209 citations) and Aging (12 citations). Ricardo Celestino has collaborated with scholars based in Portugal, Spain and United Kingdom. Frequent co-authors include Paula Soares, Manuel Sobrinho‐Simões, Reto Gassmann, Ana Xavier Carvalho, Patrícia Castro, José B. Gama, Catarina Eloy, João Vinagre, Valdemar Máximo and Jorge Lima. Their work appears in journals such as SHILAP Revista de lepidopterología, The Journal of Cell Biology and Current Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026